Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic

Shenghui Weng1, Hang Ruan1

  • 1Institutes of Biology and Medical Sciences, Soochow University, China.

The FEBS Journal
|December 3, 2022
PubMed

Insights

Synthetic lethality (SL) uses gene pairs to kill cancer cells while sparing normal cells. This study systematically maps cancer-specific SL interactions, aiding the discovery of new cancer drug targets.

Area of Science:

  • Oncology
  • Genetics
  • Computational Biology

Background:

  • Synthetic lethality (SL) involves gene pairs where mutations in both are lethal, but in only one are non-lethal.
  • SL-based therapeutics offer targeted cancer cell killing, sparing healthy cells.
  • Existing SL resources lack systematic analysis of the molecular features of SL genes.

Purpose of the Study:

  • To systematically analyze cancer-specific synthetic lethality interactions.
  • To explore the molecular characteristics of genes involved in synthetic lethality.
  • To identify potential new targets for anticancer therapeutics.

Main Methods:

  • Comprehensive multi-omics data analysis.
  • Computational screening of large-scale genetic interaction datasets.
  • Experimental validation of a specific synthetic lethality gene pair.

Main Results:

  • A systematic map of cancer-specific SL interactions was generated.
  • Insights into the molecular features distinguishing SL genes were gained.
  • One SL gene pair was experimentally validated, demonstrating feasibility.

Conclusions:

  • Systematic analysis of SL interactions enhances understanding of carcinogenesis.
  • The generated map can guide the screening of novel anticancer therapeutic targets.
  • This approach holds promise for developing more precise cancer treatments.